These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15781129

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hepatitis B virus genetic diversity.
    Echevarría JM, Avellón A.
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum.
    Lin HW, Sun MX, Wang YH, Yang LM, Yang YR, Huang N, Xuan LJ, Xu YM, Bai DL, Zheng YT, Xiao K.
    Planta Med; 2010 Jun; 76(9):889-92. PubMed ID: 20112182
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
    Ren X, Luo G, Xie Z, Zhou L, Kong X, Xu A.
    J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
    [Abstract] [Full Text] [Related]

  • 27. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
    Le XH, Chen XC, Lin Q, Li MZ, Wang M, Liu SY, Yu ZY, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
    [Abstract] [Full Text] [Related]

  • 28. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes.
    Shin MS, Kang EH, Lee YI.
    Antiviral Res; 2005 Sep; 67(3):163-8. PubMed ID: 16118024
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
    Han YQ, Huang ZM, Yang XB, Liu HZ, Wu GX.
    J Ethnopharmacol; 2008 Jun 19; 118(1):148-53. PubMed ID: 18495393
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan 19; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct 19; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages.
    Kim KW, Ha KT, Park CS, Jin UH, Chang HW, Lee IS, Kim CH.
    Vascul Pharmacol; 2007 Oct 19; 47(2-3):99-107. PubMed ID: 17553752
    [Abstract] [Full Text] [Related]

  • 38. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J, Tang ZM, Gao X, Zhao F, Zhong H, Wen MR, Sun X, Song HF, Qian XH.
    Acta Pharmacol Sin; 2008 Dec 19; 29(12):1522-8. PubMed ID: 19026173
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.